2010 CBA Annual Conference
Click here to load reader
description
Transcript of 2010 CBA Annual Conference
CBA 2010 Annual Conference A Sea Change: Advancement in Biotech and Pharmaceutical Industry
12:00-1:00 Registration
1:00–1:10 Welcome Remarks
1:10–3:15 Plenary Session Opportunities and Challenges in the Development of Novel Small Molecule Therapeutics for
Oncology Dr. Peter Lamb, CSO and Executive VP Discovery, Exelixis
Obstacles to the Commercialization of the First Inhaled Insulin Product, Exubera Dr. John Patton, Founder and CEO, Dance Pharmaceuticals
Title (TBD) Dr. Kevin Moore, Executive Director, Amgen
Kaletra: a Second Generation Protease Inhibitor From Abbott Laboratories Dr. Hing Sham, Senior VP, Chemical Sciences, Elan Pharmaceuticals
Landscape and Industry Outlook of In Vitro Diagnostics Dr. Jimmy Zhang, Senior VP, Synergenics
3:15–3:40 Coffee Break
3:40–5:45 Advances in Diagnostics and Biomarkers New Waves in Therapeutic Drug Development
Translating Gene Expression Patterns into Commercialized Cancer Diagnostics Dr. Douglas Ross, CSO, Clarient Inc.
4
Strategies for Developing Pharmacodynamic and Predictive Biomarkers to Target Cancer Stem Cell Agents Dr. Ann Kapoun, Senior Director Translational Medicine, OncoMed Pharmaceuticals
RNAscope™, a Novel RNA In Situ Hybridization Platform for Personalized Medicine Dr. Yuling Luo, Founder, President and CEO, Advanced Cell Diagnostics Inc.
Introducing a Novel, Semiconductor Chip-Based Platform for DNA Biomarker Discovery and Personalized Medicine Dr. Gary Zweiger, VP, Business Development, BioNanomatrix Inc Panel Discussion
Capturing the Value of a Drug Before It Hits the Market
New Strategies in Drug Development from an Investor's Point of View Dr. Jim Larrick, TENEX Medical Investors & 7X Investment Fund
Changing Business Model for Changing Times: the Rise of Virtual Innovation
Dr. Yiyou Chen, CSO & Co-founder, Crown Biosciences
Generation of Customized Medicines through Molecular Profiling
Conducting Personalized Medicine with the Assistance of Biostatisticians. Dr. Xiaowei Yang, CEO, BayesSoft
Next Generation Biology through next Generation DNA Sequencing Dr. Dawei Lin, Director Bioinformatics Core, UC Davis
Data-Driven Drug Discovery and Personalized Medicine Mr. Joel Dudley, Bioinformatics Specialist, Butte Lab
6:00–6:45 Networking Mixer and Exhibits
6:45–9:00 Dinner, Keynote and Live Entertainment
Keynote Seminar: ‘The Great Recession’: How US consumer is reacting to it and the implications for international trade
Professor David Robinson, Haas Business School, UC Berkeley & Santa Clara University